Account
Bayer suggested there was room to lift prices at its high-tech plastics and chemicals business this year to counter soaring raw material costs that squeezed first quarter margins.The diversified healthcare group's MaterialScience division, global market leader in polycarbonate plastics used in blu-ray discs and car lights, lowered its outlook last month as a result of the soaring costs of petrochemicals such as benzene.But on Friday the unit's top executive, Patrick Thomas, told Reuters it had leeway to combat the problem by raising prices."We're in markets where you can recover as long as the supply-demand balance is at appropriate level," Thomas said in an interview. "The elasticity in the market place is sufficient.""The real concern would be if high benzene prices were to structurally make our materials uncompetitive. That's not true."The unit, which also makes chemicals for insulation foam, constitutes the higher-margin chemicals business that remained after Bayer spun off what is...
German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Wednesday Joerg Reinhardt, chief of Bayer HealthCare, won't renew his contract with the company an...
Bayer inked a deal on Tuesday to buy Schiff Nutrition International (NYSE:SHF) for $1.2 billion in an effort to bolster its position in the U.S.The $34-a-share trans...
Bayer AG (BAYN.XE) Chief Executive Marijn Dekkers said Thursday organic growth is his priority but didn't rule out acquisitions in the coming years.His statement cam...
German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Thursday it "is increasingly confident for the rest of the year" after a good first quarter with f...
Bayer AG (BAYN.XE) views organic growth as the chemical and pharmaceutical company's most important target, Chief Executive Marijn Dekkers told journalists late Wedn...
German pharmaceutical company Bayer AG (BAYN.XE) is sticking to its target of doubling turnover in China by 2015, Chief Executive Marijn Dekkers tells the Frankfurte...
Bayer AG, the Leverkusen, Germany, health-care group, swung to a fourth-quarter profit from a year-earlier loss on 2% higher sales. Net income was €397 million ($533...
In an effort to strengthen its contraceptive portfolio, German drug and chemical maker Bayer unveiled an all-cash deal on Monday to acquire birth-control maker Conce...
Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion (852 million euros) as the health-care firm aims to broaden its women's cont...
Bayer AG on Monday said it will buy Conceptus, Inc. , whose flagship product is a surgery-free permanent birth control method, for $1.1 billion. Bayer intends to ext...
Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's heal...
Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience...
Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience...
German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Tuesday it plans to increase its dividend for 2012 to 1.90 euros ($2.51) a share from EUR1.65 in 2...
